X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs SUVEN LIFE - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH SUVEN LIFE PANACEA BIOTECH/
SUVEN LIFE
 
P/E (TTM) x 80.0 16.4 487.6% View Chart
P/BV x 1.8 3.0 58.4% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 PANACEA BIOTECH   SUVEN LIFE
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
SUVEN LIFE
Mar-16
PANACEA BIOTECH/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs149339 43.9%   
Low Rs82144 57.0%   
Sales per share (Unadj.) Rs84.139.2 214.4%  
Earnings per share (Unadj.) Rs-18.37.5 -245.4%  
Cash flow per share (Unadj.) Rs-6.78.8 -76.3%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs83.749.0 170.8%  
Shares outstanding (eoy) m61.25127.28 48.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.46.2 22.3%   
Avg P/E ratio x-6.332.4 -19.5%  
P/CF ratio (eoy) x-17.227.5 -62.7%  
Price / Book Value ratio x1.44.9 28.0%  
Dividend payout %026.8 0.0%   
Avg Mkt Cap Rs m7,07430,732 23.0%   
No. of employees `0002.81.0 288.3%   
Total wages/salary Rs m1,449416 348.0%   
Avg. sales/employee Rs Th1,874.15,236.1 35.8%   
Avg. wages/employee Rs Th527.0436.5 120.7%   
Avg. net profit/employee Rs Th-407.7995.5 -41.0%   
INCOME DATA
Net Sales Rs m5,1544,995 103.2%  
Other income Rs m100194 51.6%   
Total revenues Rs m5,2545,189 101.2%   
Gross profit Rs m-7661,233 -62.2%  
Depreciation Rs m711167 425.2%   
Interest Rs m1,50354 2,773.1%   
Profit before tax Rs m-2,8811,205 -239.1%   
Minority Interest Rs m110-   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,7710-   
Tax Rs m17255 6.6%   
Profit after tax Rs m-1,121950 -118.1%  
Gross profit margin %-14.924.7 -60.3%  
Effective tax rate %-0.621.2 -2.8%   
Net profit margin %-21.819.0 -114.4%  
BALANCE SHEET DATA
Current assets Rs m3,8104,986 76.4%   
Current liabilities Rs m8,3651,042 802.6%   
Net working cap to sales %-88.479.0 -111.9%  
Current ratio x0.54.8 9.5%  
Inventory Days Days15661 255.3%  
Debtors Days Days6739 171.8%  
Net fixed assets Rs m14,4803,126 463.3%   
Share capital Rs m61127 48.2%   
"Free" reserves Rs m9033,717 24.3%   
Net worth Rs m5,1276,236 82.2%   
Long term debt Rs m5,832432 1,349.0%   
Total assets Rs m19,4338,079 240.5%  
Interest coverage x-0.923.2 -3.9%   
Debt to equity ratio x1.10.1 1,640.8%  
Sales to assets ratio x0.30.6 42.9%   
Return on assets %2.012.4 15.8%  
Return on equity %-21.915.2 -143.6%  
Return on capital %3.618.9 19.3%  
Exports to sales %24.587.5 28.0%   
Imports to sales %10.212.2 83.3%   
Exports (fob) Rs m1,2644,371 28.9%   
Imports (cif) Rs m525611 85.9%   
Fx inflow Rs m1,5394,666 33.0%   
Fx outflow Rs m942942 100.0%   
Net fx Rs m5973,724 16.0%   
CASH FLOW
From Operations Rs m599922 65.0%  
From Investments Rs m-438-619 70.7%  
From Financial Activity Rs m-303-698 43.3%  
Net Cashflow Rs m-141-396 35.7%  

Share Holding

Indian Promoters % 74.5 63.4 117.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 0.0 -  
FIIs % 1.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 36.5 64.7%  
Shareholders   10,259 37,287 27.5%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   WOCKHARDT LTD.  J.B.CHEMICALS  MERCK LTD  DIVIS LABORATORIES  FULFORD INDIA  

Compare PANACEA BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Aug 23, 2017 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS